Effective anti-Alzheimer Aβ therapy involves depletion of specific Aβ oligomer subtypes.

Effective anti-Alzheimer Aβ therapy involves depletion of specific Aβ oligomer subtypes.

Item
http://www.wikidata.org/entity/Q36894417
Lysosomal dysfunction in the brain of a mouse model with intraneuronal accumulation of carboxyl terminal fragments of the amyloid precursor protein.Antibody Engineering & Therapeutics 2016: The Antibody Society's annual meeting, December 11-15, 2016, San Diego, CAAlzheimer's Toxic Amyloid Beta Oligomers: Unwelcome Visitors to the Na/K ATPase alpha3 Docking Station.Alzheimer's disease: experimental models and reality.Production of Monoclonal Antibodies to Pathologic β-sheet Oligomeric Conformers in Neurodegenerative Diseases.A box of chocolatesDeficiency of TYROBP, an adapter protein for TREM2 and CR3 receptors, is neuroprotective in a mouse model of early Alzheimer's pathology.Discrete pools of oligomeric amyloid-β track with spatial learning deficits in a mouse model of Alzheimer amyloidosis.Vitamin D in the prevention, prediction and treatment of neurodegenerative and neuroinflammatory diseases.Anti-β-sheet conformation monoclonal antibody reduces tau and Aβ oligomer pathology in an Alzheimer's disease model.Early long-term administration of the CSF1R inhibitor PLX3397 ablates microglia and reduces accumulation of intraneuronal amyloid, neuritic plaque deposition and pre-fibrillar oligomers in 5XFAD mouse model of Alzheimer's disease.Metformin Attenuates Aβ Pathology Mediated Through Levamisole Sensitive Nicotinic Acetylcholine Receptors in a C. elegans Model of Alzheimer's Disease.Alzheimer's Disease, Oligomers, and Inflammation.Combination anti-Aβ treatment maximizes cognitive recovery and rebalances mTOR signaling in APP mice.The Amyloid-β Oligomer Hypothesis: Beginning of the Third Decade.Immunotherapy to improve cognition and reduce pathological species in an Alzheimer's disease mouse model.
P2860

Effective anti-Alzheimer Aβ therapy involves depletion of specific Aβ oligomer subtypes.

Item
http://www.wikidata.org/entity/Q36894417
description
2016 nî lūn-bûn
@nan
2016年の論文
@ja
2016年論文
@yue
2016年論文
@zh-hant
2016年論文
@zh-hk
2016年論文
@zh-mo
2016年論文
@zh-tw
2016年论文
@wuu
2016年论文
@zh
2016年论文
@zh-cn
name
Effective anti-Alzheimer Aβ therapy involves depletion of specific Aβ oligomer subtypes.
@en
type
label
Effective anti-Alzheimer Aβ therapy involves depletion of specific Aβ oligomer subtypes.
@en
prefLabel
Effective anti-Alzheimer Aβ therapy involves depletion of specific Aβ oligomer subtypes.
@en
P1433
P1476
P2093
P2860
P304
P31
P356
P433
P478
P577
P698
P921
P932
P356
P1433
P1476
Effective anti-Alzheimer Aβ therapy involves depletion of specific Aβ oligomer subtypes.
@en
P2093
P2860
P304
P31
P356
10.1212/NXI.0000000000000237
P433
P478
P577
P698
P921
P932